Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SIRT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NFKBIB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGALS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGALS7B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAPN12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on